ArticleJournal for immunotherapy of cancer2024

Type I MET inhibitors cooperate with PD-1 blockade to promote rejection of hepatocellular carcinoma.

Ricardo DeAzevedo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.